146 related articles for article (PubMed ID: 18801826)
1. Olanzapine-induced hyperglycaemic coma and neuroleptic malignant syndrome: case report and review of literature.
Ahuja N; Palanichamy N; Mackin P; Lloyd A
J Psychopharmacol; 2010 Jan; 24(1):125-30. PubMed ID: 18801826
[TBL] [Abstract][Full Text] [Related]
2. Reversible splenial lesion syndrome with a hyperosmolar hyperglycemic state and neuroleptic malignant syndrome caused by olanzapine.
Kaino K; Kumagai R; Furukawa S; Isono M; Muramatsu A; Fujii M; Muta Y; Asada T; Fujihara K; Yagyu H
J Diabetes Investig; 2017 May; 8(3):392-394. PubMed ID: 27863115
[TBL] [Abstract][Full Text] [Related]
3. New-onset type II diabetes mellitus, hyperosmolar non-ketotic coma, rhabdomyolysis and acute renal failure in a patient treated with sulpiride.
Toprak O; Cirit M; Ersoy R; Uzüm A; Ozümer O; Cobanoğlu A; Tanrisev M; Güleç D; Cetinkalp S
Nephrol Dial Transplant; 2005 Mar; 20(3):662-3. PubMed ID: 15735255
[No Abstract] [Full Text] [Related]
4. Antipsychotic Therapy-Induced New Onset Diabetic Ketoacidosis.
Agrawal Y; Lingala K; Tokala H; Kalavakunta JK
Am J Ther; 2016; 23(6):e1944-e1945. PubMed ID: 26741957
[TBL] [Abstract][Full Text] [Related]
5. Hyperosmolar hyperglycemic state secondary to neuroleptic malignant syndrome.
Takanobu K; Okazaki D; Ogawa T; Watanabe S; Oka M; Murakami S; Ura H
Am J Emerg Med; 2015 Jan; 33(1):126.e1-2. PubMed ID: 25151326
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine induced neuroleptic malignant syndrome.
Patra BN; Khandelwal SK; Sood M
Indian J Pharmacol; 2013; 45(1):98-9. PubMed ID: 23543750
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome associated with the use of prochlorperazine in a patient with a recent history of antipsychotic-induced neuroleptic malignant syndrome.
Musselman ME; Browning LA; Parker D; Saely S
Ann Pharmacother; 2011 Nov; 45(11):e61. PubMed ID: 21972252
[TBL] [Abstract][Full Text] [Related]
8. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
Khaldi S; Kornreich C; Choubani Z; Gourevitch R
Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
[TBL] [Abstract][Full Text] [Related]
9. Neuroleptic malignant syndrome presenting as hyperosmolar non-ketotic diabetic coma.
Balzan M; Cacciottolo JM
Br J Psychiatry; 1992 Aug; 161():257-8. PubMed ID: 1521110
[TBL] [Abstract][Full Text] [Related]
10. Atypical neuroleptic malignant syndrome caused by olanzapine.
Nielsen J; Bruhn AM
Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
[TBL] [Abstract][Full Text] [Related]
11. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.
Mishra B; Mishra B; Sahoo S; Arora M; Khess CR
Indian J Med Sci; 2007 Oct; 61(10):570-3. PubMed ID: 17932448
[TBL] [Abstract][Full Text] [Related]
12. Olanzapine-lnduced hyperglycemic nonketonic coma.
Roefaro J; Mukherjee SM
Ann Pharmacother; 2001 Mar; 35(3):300-2. PubMed ID: 11261526
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine-associated neuroleptic malignant syndrome in a patient receiving concomitant rivastigmine therapy.
Stevens DL; Lee MR; Padua Y
Pharmacotherapy; 2008 Mar; 28(3):403-5. PubMed ID: 18294120
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome associated with olanzapine.
Filice GA; McDougall BC; Ercan-Fang N; Billington CJ
Ann Pharmacother; 1998 Nov; 32(11):1158-9. PubMed ID: 9825080
[TBL] [Abstract][Full Text] [Related]
15. [Electroconvulsion therapy for neuroleptic malignant syndrome].
Buggenhout S; Vandenberghe J; Sienaert P
Tijdschr Psychiatr; 2014; 56(9):612-5. PubMed ID: 25222100
[TBL] [Abstract][Full Text] [Related]
16. Neuroleptic malignant syndrome due to three atypical antipsychotics in a child.
Chungh DS; Kim BN; Cho SC
J Psychopharmacol; 2005 Jul; 19(4):422-5. PubMed ID: 15982999
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine-induced neuroleptic malignant syndrome in a patient with paranoid schizophrenia.
Srivastava A; Borkar HA; Chandak S
Psychiatry Clin Neurosci; 2009 Feb; 63(1):119-21. PubMed ID: 19067992
[TBL] [Abstract][Full Text] [Related]
18. [Neuroleptic malignant syndrome. Case reports].
Berardi D; Troia M; Veronesi L; Ferrari G
Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
[TBL] [Abstract][Full Text] [Related]
19. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
Lee JW
Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine induced neuroleptic malignant syndrome--a case review.
Kogoj A; Velikonja I
Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
